Pages that link to "Q35941563"

The following pages link to Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia (Q35941563):

Displaying 47 items.

• Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes (Q27006535) (← links)
• Biliary atresia: cellular dynamics and immune dysregulation (Q27022702) (← links)
• Biliary atresia: recent progress (Q33670749) (← links)
• Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease (Q33831666) (← links)
• Biliary atresia: will blocking inflammation tame the disease? (Q33894858) (← links)
• Staging of biliary atresia at diagnosis by molecular profiling of the liver (Q33918828) (← links)
• Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. (Q33947872) (← links)
• Low doses of CMV induce autoimmune-mediated and inflammatory responses in bile duct epithelia of regulatory T cell-depleted neonatal mice (Q34455128) (← links)
• RRAS: A key regulator and an important prognostic biomarker in biliary atresia (Q34591240) (← links)
• The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease (Q34660377) (← links)
• Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype (Q35484899) (← links)
• What Causes Biliary Atresia? Unique Aspects of the Neonatal Immune System Provide Clues to Disease Pathogenesis (Q35743910) (← links)
• Dendritic Cells Regulate Treg-Th17 Axis in Obstructive Phase of Bile Duct Injury in Murine Biliary Atresia (Q35760835) (← links)
• Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells (Q35870141) (← links)
• Rhesus rotavirus VP4 sequence-specific activation of mononuclear cells is associated with cholangiopathy in murine biliary atresia (Q36066437) (← links)
• Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. (Q36586836) (← links)
• Lack of HLA predominance and HLA shared epitopes in biliary Atresia (Q36678291) (← links)
• Aetiology of biliary atresia: what is actually known? (Q37153740) (← links)
• α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia (Q37219150) (← links)
• Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia (Q37286636) (← links)
• Clues to the etiology of bile duct injury in biliary atresia (Q37308079) (← links)
• Advances in biliary atresia: from patient care to research (Q37750516) (← links)
• Liver fibrosis in biliary atresia (Q37763083) (← links)
• T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction (Q38033651) (← links)
• Hepatic expression of multidrug resistance protein 2 in biliary atresia. (Q38261468) (← links)
• Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia (Q40364765) (← links)
• The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia (Q40576425) (← links)
• Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia (Q41836370) (← links)
• Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia (Q42209576) (← links)
• CD8+ T lymphocyte response against extrahepatic biliary epithelium is activated by epitopes within NSP4 in experimental biliary atresia (Q42216044) (← links)
• Swiss outcomes in biliary atresia: are there lessons to be learned? (Q42705075) (← links)
• Corticosteroid treatment in biliary atresia: Tonic or toast? (Q42746499) (← links)
• Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia (Q43657474) (← links)
• Update on investigations pertaining to the pathogenesis of biliary atresia (Q50075063) (← links)
• Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis. (Q52561169) (← links)
• BILIARY ATRESIA: Clinical and Research Challenges for the 21st Century. (Q52617019) (← links)
• Biliary atresia (Q56390042) (← links)
• Combinatory effects of hepatic CD8+ and NK lymphocytes in bile duct injury from biliary atresia (Q56898091) (← links)
• Cytokine-producing B cells promote immune-mediated bile duct injury in murine biliary atresia (Q57120538) (← links)
• A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice (Q58122453) (← links)
• Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy (Q64055196) (← links)
• Oligoclonal immunoglobulin repertoire in biliary remnants of biliary atresia (Q64096060) (← links)
• Cooperation of innate and adaptive immunity in the pathogenesis of biliary atresia: there's a killer on the run (Q84950155) (← links)
• T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions (Q85073558) (← links)
• Innate Immunity and Pathogenesis of Biliary Atresia (Q90248456) (← links)
• The Prognostic Value of CD8+ and CD45RO+ T Cells Infiltration and Beclin1 Expression Levels for Early Postoperative Cholangitis of Biliary Atresia Patients after Kasai Operation (Q90400806) (← links)
• Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms and biliary atresia susceptibility in Chinese children (Q92646452) (← links)